Living with MS: Exploring Cannabis Treatment Options
Some people living with multiple sclerosis ask whether cannabis or cannabinoid-based products may help manage symptoms such as pain or muscle spasticity. Research suggests possible benefit for certain symptoms in some patients, particularly with some non-inhaled cannabinoid products, but results vary by symptom, formulation, and individual response. Cannabis does not cure MS, slow the disease, or replace disease-modifying treatment. Its potential benefits, side effects, medication interactions, impairment risks, and individual suitability should be reviewed with qualified healthcare professionals.
At Comprehensive Pain Management Associates, we provide pain management services in Jericho, New York, and our medical cannabis service specifically identifies pain related to multiple sclerosis among the conditions for which medical cannabis may be considered. Our goal is to evaluate pain-management options in the context of each patient’s needs rather than assume that one treatment is appropriate for everyone.
What Role Can Cannabis Play in MS Symptom Management?
Multiple sclerosis is a chronic disease involving the central nervous system, which includes the brain and spinal cord. Depending on the individual, MS may cause symptoms such as muscle stiffness or spasms, weakness, numbness or altered sensation, pain, fatigue, balance difficulties, bladder concerns, and cognitive changes. Symptoms and their severity can differ significantly from one person to another.
This distinction matters when discussing cannabis treatment options for MS. Cannabis is generally considered in the context of symptom management, not treatment of the underlying disease itself.
Research reviewed by the National Multiple Sclerosis Society has examined cannabinoids for MS-related spasticity, pain, and some bladder symptoms. Some studies suggest that certain non-inhaled cannabinoids may offer modest benefit for spasticity or pain in some people, but studies have often been relatively small and results have varied. Evidence supporting one symptom should not automatically be applied to another.
For someone considering medical cannabis for MS-related symptoms, the more useful question is therefore not simply, “Does cannabis work for MS?” Instead, the discussion should focus on which symptom is being addressed, what evidence exists for that particular symptom, what other treatments are being used, and what individual risks need to be considered.
Cannabis Does Not Replace MS Disease-Modifying Treatment
Symptom management and disease modification are different treatment goals.
Disease-modifying therapies are used as part of neurological MS care to influence disease activity and, depending on the type of MS and therapy involved, may reduce relapses or delay aspects of disease progression. Symptom-focused treatments are intended to address problems such as pain, stiffness, fatigue, or other effects of MS.
Cannabis should not be viewed as a substitute for disease-modifying therapy, neurological follow-up, physical therapy, rehabilitation, or other established MS care. There is no basis for claiming that cannabis cures MS, repairs nerve damage, restores myelin, prevents relapses, eliminates lesions, or stops disease progression. The National Multiple Sclerosis Society also notes that there are currently no FDA-approved cannabis-based medications specifically for treating MS symptoms in the United States.
Patients should not stop, reduce, or change an MS medication because they are considering cannabis or believe a symptom has improved. Medication changes should be discussed with the clinicians managing their MS.
Which MS Symptoms Have Been Studied?
Spasticity
Spasticity refers to muscle tightness or stiffness that can interfere with movement and comfort. It is a common MS symptom, although it does not affect everyone in the same way.
Research involving certain non-inhaled cannabinoid preparations suggests that some patients may experience improvement in spasticity symptoms. However, benefits are not universal, and the type of cannabinoid product studied matters when interpreting the evidence.
Pain
Pain in MS can have different causes, including nerve-related pain and painful muscle spasms. Because the underlying causes vary, pain treatment should be individualized.
Cannabinoids have been studied for MS-related pain, with some evidence suggesting possible benefit for certain patients. The available research does not support a guarantee of pain relief or the assumption that cannabis is more effective than conventional pain-management approaches.
At our Jericho practice, pain related to multiple sclerosis is specifically identified within our medical cannabis service. An evaluation can help place that option within a broader pain-management discussion rather than considering cannabis in isolation.
THC and CBD Are Not the Same
Two commonly discussed cannabinoids are tetrahydrocannabinol, or THC, and cannabidiol, or CBD. They should not be treated as interchangeable.
THC can produce intoxicating and mind-altering effects. CBD does not produce the same type of intoxication, but that does not mean CBD is automatically risk-free. Cannabis and cannabis-derived products can differ substantially in cannabinoid composition, and effects can depend on the specific formulation and individual using it.
FDA approval is another important distinction. State-authorized medical cannabis products are not the same as FDA-approved medications. The FDA-approved prescription CBD product Epidiolex is indicated for seizures associated with specific seizure disorders, not multiple sclerosis. Its approval should not be interpreted as FDA approval of CBD generally or of cannabis for MS.
Patients should therefore be cautious about broad claims that a particular THC or CBD product “treats MS.” Evidence needs to be considered according to the cannabinoid, formulation, symptom, and clinical outcome actually studied.
Potential Side Effects and Safety Considerations
Medical cannabis is not risk-free. Depending on the cannabinoid content, product, amount used, individual sensitivity, and other health factors, potential effects can include:
- Drowsiness or fatigue
- Dizziness or unsteadiness
- Changes in attention or memory
- Impaired coordination
- Changes in judgment or perception
- Anxiety or other uncomfortable psychological effects
People with MS may already experience balance problems, fatigue, cognitive changes, or dizziness, which can make certain cannabis-related effects particularly relevant when weighing risks and possible benefits.
Cannabis can also become problematic for some individuals. The National Institute on Drug Abuse recognizes cannabis use disorder as a potential health concern and continues to study dependence, withdrawal, mental health effects, and other consequences associated with cannabis use. A personal or family psychiatric history and a history of problematic substance use are important factors to discuss honestly with a healthcare professional.
Cannabis and Other Medications
People with MS may take several medications for disease modification, pain, muscle symptoms, sleep, mood, or other health conditions. Cannabis and cannabinoids should not be assumed to combine safely with every prescription medication, over-the-counter medicine, supplement, alcohol, or sedating substance.
CBD itself can interact with drug-metabolizing pathways, and the FDA warns that CBD can cause side effects and clinically relevant medication interactions.
Before considering cannabis, patients should provide their healthcare professionals with an accurate list of medications and supplements. This review should be used to assess possible risks, not as a reason to independently stop or adjust an existing prescription.
Driving, Pregnancy, and Other Situations Requiring Extra Caution
Cannabis containing intoxicating cannabinoids can impair reaction time, coordination, decision-making, perception, and other abilities needed for safe driving. The CDC advises against driving while impaired, and New York specifically prohibits driving under the influence of cannabis.
Legal access to cannabis does not make impaired driving safe or lawful.
Pregnancy, attempts to conceive, and breastfeeding also require special caution. CDC guidance recommends avoiding cannabis during pregnancy and encourages breastfeeding individuals to avoid cannabis because cannabinoids, including THC, may expose the developing baby or infant. People who are pregnant, planning pregnancy, or breastfeeding should discuss any cannabis use with their healthcare professionals.
Additional caution may also be appropriate for people with cardiovascular concerns, significant anxiety, a history of psychosis, substance use concerns, or medications that could increase sedation or other adverse effects.
Understanding Medical Cannabis in New York
New York currently operates a Medical Cannabis Program through the Office of Cannabis Management. Under the present program, a New York State healthcare provider who meets the state’s requirements may certify a patient for medical cannabis when the provider determines it is medically appropriate. The state’s patient information specifically identifies multiple sclerosis among conditions for which patients may use medical cannabis.
Certification and legal access do not mean medical cannabis is appropriate for every person with MS. Individual medical suitability still depends on symptoms, health history, current medications, possible interactions, and risk factors.
New York cannabis rules can also change. Patients should review current Office of Cannabis Management guidance and discuss medical questions with qualified healthcare professionals rather than relying on older eligibility or program information.
Discussing MS Pain With a Pain Management Specialist
When pain becomes a meaningful part of living with MS, pain management may complement the care provided by a neurologist and other members of the healthcare team.
At Comprehensive Pain Management Associates in Jericho, we evaluate patients experiencing chronic and neuropathic pain and provide medical cannabis as one of our verified pain-management services. Our practice describes a thorough evaluation process and individualized treatment planning rather than assuming every patient requires the same medication, procedure, or therapy.
For someone with MS, that conversation may include the character of the pain, other symptoms, current treatment, medications, previous pain-management approaches, and whether medical cannabis or another pain-management strategy is medically appropriate.
Cannabis should remain one possible topic within a broader care plan, not a replacement for ongoing neurological management of MS.
Frequently Asked Questions
1. Can cannabis cure multiple sclerosis?
No. Cannabis has not been shown to cure, reverse, or stop multiple sclerosis. Research involving cannabinoids has focused primarily on managing certain symptoms, such as spasticity and pain, rather than modifying the underlying MS disease process.
2. Can cannabis help with MS-related pain or spasticity?
Certain non-inhaled cannabinoids have shown possible benefit for pain and spasticity in some people with MS, but results vary and the evidence does not support guaranteed relief. The potential benefit depends on the symptom, formulation, individual response, and other medical factors.
3. What is the difference between THC and CBD?
THC and CBD are different cannabinoids. THC can cause intoxication and changes in perception, coordination, and judgment. CBD does not cause the same type of intoxication, but it can still have side effects and interact with medications. Products containing THC, CBD, or combinations of cannabinoids should not be treated as medically equivalent.
4. Is medical cannabis available for people with MS in New York?
New York’s Medical Cannabis Program allows appropriately qualified healthcare providers to certify patients when medical cannabis is considered suitable, and the state’s patient guidance lists multiple sclerosis among conditions associated with medical cannabis use. Eligibility and medical appropriateness should still be determined individually.
5. Can cannabis interact with prescription medications?
Yes. Cannabis and individual cannabinoids may interact with certain medications or increase effects such as drowsiness or impairment. Patients should discuss all prescription medications, over-the-counter drugs, and supplements with qualified healthcare professionals before considering cannabis. They should not stop or alter prescribed MS treatment on their own.
Explore MS Pain Management and Medical Cannabis Options in Jericho
If MS-related pain is affecting your comfort or daily activities, we can help you explore medically appropriate pain-management options. Comprehensive Pain Management Associates provides pain management and medical cannabis services at our Jericho, New York practice, including care for pain associated with multiple sclerosis.
Contact our team to schedule an evaluation and discuss your symptoms, health history, current medications, and treatment goals. Any decision involving medical cannabis should be individualized and coordinated appropriately with the healthcare professionals managing your MS.
This article is for general educational purposes and is not a substitute for individualized medical advice. Treatment decisions should be made with qualified healthcare professionals who understand your health history and current medications.